Among the inhibitory mechanisms, the effect of SPARC on metabolism is mainly to inhibit the metabolic reprogramming of adipocytes and ovarian cancer cells, inhibit adipocyte differentiation, and inhibit adipocytes from acquiring cancer-related phenotypes [111]. This evidence concerns the gene SPARC and ovarian carcinoma.